Stay updated on RTX-240 Combo with Pembrolizumab in Clinical Trial

Sign up to get notified when there's something new on the RTX-240 Combo with Pembrolizumab in Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RTX-240 Combo with Pembrolizumab in Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new revision entry for v3.6.4 has been added to the page's history, replacing the previous v3.6.3 entry. This reflects an internal update to the record history metadata rather than changes to the visible study information.
    Difference
    0.1%
    Check dated 2026-07-21T12:46:55.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new study record revision v3.6.3 was added to the history and the older revision v3.6.0 was removed, reflecting an update to the record's documentation.
    Difference
    0.1%
    Check dated 2026-06-30T02:01:11.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Recruitment for RTX-240 is no longer open, indicating a closed enrollment status in the study history. The record now shows Revision: v3.6.0 (replacing the prior v3.5.5).
    Difference
    0.5%
    Check dated 2026-06-15T18:20:29.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    A new release note 'Revision: v3.5.5' was added to the page history. The previous release note 'Revision: v3.5.4' was removed.
    Difference
    0.1%
    Check dated 2026-06-08T14:42:06.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 is added to the Record History, replacing the previous v3.5.3 entry.
    Difference
    0.1%
    Check dated 2026-05-18T03:44:06.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page’s footer revision label has been updated from **v3.5.0** to **v3.5.3**, reflecting a site/version change rather than any modification to the underlying study record.
    Difference
    0.1%
    Check dated 2026-04-26T15:25:28.000Z thumbnail image

Stay in the know with updates to RTX-240 Combo with Pembrolizumab in Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RTX-240 Combo with Pembrolizumab in Clinical Trial page.